BIVALENT INACTIVATED EV71-CA16 VACCINE, METHOD FOR PREPARING THE SAME, AND USE THEREOF

Coxsackievirus 83 Vaccine

MIR-375- AND MIR-1-REGULATED COXSACKIEVIRUS B3 HAS NO PANCREAS AND HEART TOXICITY BUT STRONG ANTITUMOR EFFICIENCY IN COLORECTAL CARCINOMAS

ANTITUMOR VIRUS

PHARMACEUTICAL COMPOSITION CONTAINING STABILIZED NUCLEIC ACID ADJUVANT

Virus for treatment of tumor

CHIMERIC ENTEROVIRUS VIRUS-LIKE PARTICLES

Combination method for treatment of cancer

Sequential anti-cancer treatment

Method for treating cancer with a Coxsackievirus B3 (CVB3) variant

Antigens and vaccines directed against human enteroviruses

Antigens and vaccines directed against human enteroviruses

Hand, foot, and mouth vaccines and methods of manufacture and use thereof

METHOD OF TREATING A MALIGNANCY IN A SUBJECT AND A PHARMACEUTICAL COMPOSITION FOR USE IN SAME

Adenoviral vector-based vaccine against enterovirus infection

COMBINATION METHOD FOR TREATMENT OF CANCER

METHOD OF TREATING A MALIGNANCY IN A SUBJECT AND A PHARMACEUTICAL COMPOSITION FOR USE IN SAME

VIRUS-LIKE PARTICLE VACCINES

Antigens and vaccines directed against human enteroviruses

Method of Treating a Malignancy in a Subject and a Pharmaceutical Composition for Use in Same

Methods for treating malignancies using coxsackieviruses